Journal
GENOME MEDICINE
Volume 5, Issue -, Pages -Publisher
BMC
DOI: 10.1186/gm460
Keywords
-
Categories
Funding
- Canadian Research Chairs Program
- Ontario Graduate Scholarship
- Canadian Institute of Health Research [MOP-93772]
- Ontario Ministry of Health and Long Term Care
Ask authors/readers for more resources
The ability to distinguish indolent from aggressive prostate tumors remains one of the greatest challenges in the management of this disease. Ongoing efforts to establish a panel of molecular signatures, comprising gene expression profiles, proteins, epigenetic patterns, or a combination of these alterations, are being propelled by rapid advancements in 'omics' technologies. The identification of such biomarkers in biological fluids is an especially attractive goal for clinical applications. Here, we summarize recent progress in the identifi cation of candidate prognostic biomarkers of prostate cancer using biological fluid samples.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available